The reasons might be explained that although diabetes mellitus is a progressive disease accompanied by persistent chronic inflammation results from hyperglycemia or hyperinsulinemia, which play key roles in cancer cell activity, including its initiation, promotion, and progression [25], metformin can decrease insulin resistance but cannot directly reduce abnormal insulin secretion. Here, INS is linked to Hyperinsulinemia.